|
US9200061B2
(en)
|
2004-02-06 |
2015-12-01 |
Morpho Sys AG |
Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i
|
|
AU2005235811B2
(en)
|
2004-02-06 |
2011-11-03 |
Morphosys Ag |
Anti-CD38 human antibodies and uses therefor
|
|
US20050260214A1
(en)
*
|
2004-05-12 |
2005-11-24 |
Simon Michael R |
Composition and method for introduction of RNA interference sequences into targeted cells and tissues
|
|
US20110110937A1
(en)
*
|
2004-05-12 |
2011-05-12 |
Simon Michael R |
Composition and method for introduction of rna interference sequences into targeted cells and tissues
|
|
US20060030003A1
(en)
*
|
2004-05-12 |
2006-02-09 |
Simon Michael R |
Composition and method for introduction of RNA interference sequences into targeted cells and tissues
|
|
US20050255120A1
(en)
*
|
2004-05-12 |
2005-11-17 |
Simon Michael R |
Composition and method for introduction of DNA directed RNA interference sequences into targeted cells and tissues
|
|
US20110117088A1
(en)
*
|
2004-05-12 |
2011-05-19 |
Simon Michael R |
Composition and method for introduction of rna interference sequences into targeted cells and tissues
|
|
EP3312196B1
(en)
|
2005-03-23 |
2019-07-17 |
Genmab A/S |
Antibodies against cd38 for treatment of multiple myeloma
|
|
US20090123950A1
(en)
*
|
2005-05-24 |
2009-05-14 |
Morphosys Ag |
Generation And Profiling Of Fully Human Hucal Gold®-Derived Therapeutic Antibodies Specific For Human CD38
|
|
KR20150139636A
(ko)
|
2005-10-12 |
2015-12-11 |
모르포시스 아게 |
인간 ｃｄ38에 특이적인 완전 인간 ｈｕｃａｌ ｇｏｌｄ-유도 치료 항체들의 생성 및 프로파일링
|
|
US20070106233A1
(en)
*
|
2005-10-20 |
2007-05-10 |
Percutaneous Systems, Inc. |
Systems and methods for dilating and accessing body lumens
|
|
US20100267145A1
(en)
*
|
2006-06-05 |
2010-10-21 |
Hiroshima University |
Immunocompetent cell having anti-cd38 antibody on its cell surface
|
|
US20100150941A1
(en)
*
|
2006-09-13 |
2010-06-17 |
Dso National Laboratories |
Hemagglutinin antibody and uses thereof
|
|
NZ576122A
(en)
*
|
2006-09-26 |
2012-09-28 |
Genmab As |
Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors
|
|
EP2191840A1
(en)
*
|
2008-11-28 |
2010-06-02 |
Sanofi-Aventis |
Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan
|
|
EP2191842A1
(en)
*
|
2008-11-28 |
2010-06-02 |
Sanofi-Aventis |
Antitumor combinations containing antibodies recognizing specifically CD38 and cytarabine
|
|
EP2191843A1
(en)
|
2008-11-28 |
2010-06-02 |
Sanofi-Aventis |
Antitumor combinations containing antibodies recognizing specifically CD38 and cyclophosphamide
|
|
EP2191841A1
(en)
*
|
2008-11-28 |
2010-06-02 |
Sanofi-Aventis |
Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine
|
|
EP3613774A1
(en)
|
2010-06-09 |
2020-02-26 |
Genmab A/S |
Antibodies against human cd38
|
|
KR101827048B1
(ko)
*
|
2010-08-27 |
2018-02-07 |
길리아드 바이오로직스, 인크. |
매트릭스 메탈로프로테이나제 ９에 대한 항체
|
|
CN103118706B
(zh)
|
2010-09-27 |
2016-05-18 |
莫佛塞斯公司 |
抗cd38抗体与来那度胺或硼替佐米用于治疗多发性骨髓瘤和nhl
|
|
UA112170C2
(uk)
|
2010-12-10 |
2016-08-10 |
Санофі |
Протипухлинна комбінація, що містить антитіло, яке специфічно розпізнає cd38, і бортезоміб
|
|
NZ629178A
(en)
|
2012-02-29 |
2016-09-30 |
Gilead Biologics Inc |
Antibodies to matrix metalloproteinase 9
|
|
GB201216002D0
(en)
*
|
2012-09-07 |
2012-10-24 |
Deutsches Rheuma Forschungszentrum Berlin Drfz |
Compositions adn methods
|
|
BR112015006731A2
(pt)
|
2012-09-25 |
2017-07-04 |
Morphosys Ag |
combinações e usos das mesmas
|
|
EP2914302B1
(en)
|
2012-11-05 |
2017-01-04 |
MorphoSys AG |
Radiolabelled antibody and uses thereof
|
|
KR20160113158A
(ko)
|
2014-01-27 |
2016-09-28 |
몰레큘러 템플레이츠, 인코퍼레이션. |
폴리펩티드를 전달하는 mhc 클래스 i 항원결정기
|
|
US9603927B2
(en)
|
2014-02-28 |
2017-03-28 |
Janssen Biotech, Inc. |
Combination therapies with anti-CD38 antibodies
|
|
US9732154B2
(en)
|
2014-02-28 |
2017-08-15 |
Janssen Biotech, Inc. |
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
|
|
US11142584B2
(en)
|
2014-03-11 |
2021-10-12 |
Molecular Templates, Inc. |
CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
|
|
US10815469B2
(en)
|
2014-06-11 |
2020-10-27 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties
|
|
EP3191187B1
(en)
|
2014-09-09 |
2021-07-28 |
Janssen Biotech, Inc. |
Combination therapies with anti-cd38 antibodies
|
|
JP6802791B2
(ja)
|
2014-12-04 |
2020-12-23 |
ヤンセン バイオテツク，インコーポレーテツド |
急性骨髄性白血病の治療のための抗ｃｄ３８抗体
|
|
JP6444486B2
(ja)
|
2015-02-05 |
2018-12-26 |
モレキュラー テンプレーツ, インク.Molecular Templates, Inc. |
志賀毒素ａサブユニットエフェクター領域を含む多価ｃｄ２０結合分子及びそれらの強化組成物
|
|
PL3294769T3
(pl)
|
2015-05-13 |
2021-07-05 |
Morphosys Ag |
Leczenie szpiczaka mnogiego (mm)
|
|
BR112017024877A2
(pt)
|
2015-05-20 |
2019-09-17 |
Janssen Biotech, Inc. |
anticorpo anti-cd38 e seu uso no tratamento de amiloidose de cadeia leve e outras malignidades hematológicas positivas para cd38
|
|
JP6771492B2
(ja)
|
2015-05-30 |
2020-10-21 |
モレキュラー テンプレーツ, インク.Molecular Templates, Inc. |
脱免疫化された志賀毒素ａサブユニット足場及びそれを含む細胞標的化分子
|
|
NZ777133A
(en)
|
2015-06-22 |
2025-05-02 |
Janssen Biotech Inc |
Combination therapies for heme malignancies with anti-cd38 antibodies and survivin inhibitors
|
|
US20170044265A1
(en)
|
2015-06-24 |
2017-02-16 |
Janssen Biotech, Inc. |
Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
|
|
MD3827845T2
(ro)
|
2015-11-03 |
2022-09-30 |
Janssen Biotech Inc |
Formulări subcutanate de anticorpi anti-CD38 și utilizări ale acestora
|
|
US10781261B2
(en)
|
2015-11-03 |
2020-09-22 |
Janssen Biotech, Inc. |
Subcutaneous formulations of anti-CD38 antibodies and their uses
|
|
WO2017093448A1
(en)
|
2015-12-01 |
2017-06-08 |
Genmab B.V. |
Anti-dr5 antibodies and methods of use thereof
|
|
AU2017226960B2
(en)
|
2016-03-04 |
2024-03-21 |
Morphosys Ag |
Clinical assessment of M-protein response in multiple myeloma
|
|
US20190233533A1
(en)
|
2016-06-28 |
2019-08-01 |
Umc Utrecht Holding B.V. |
Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38
|
|
JP7075134B2
(ja)
|
2016-12-07 |
2022-05-25 |
モレキュラー テンプレーツ，インク． |
部位特異的コンジュゲーションのための志賀毒素ａサブユニットエフェクターポリペプチド、志賀毒素エフェクター足場、及び細胞標的化分子
|
|
KR102590672B1
(ko)
|
2017-01-25 |
2023-10-18 |
몰레큘러 템플레이츠, 인코퍼레이션. |
탈면역된 시가 독소 a 서브유닛 이펙터 및 cd8+ t-세포 에피토프를 포함하는 세포-표적화 분자
|
|
MA50514A
(fr)
|
2017-10-31 |
2020-09-09 |
Janssen Biotech Inc |
Méthodes de traitement du myélome multiple à haut risque
|
|
US20230158070A1
(en)
|
2018-01-30 |
2023-05-25 |
Cellectis |
Combination comprising allogeneic immune cells deficient for an antigen present on both t-cells and pathological cells and therapeutic antibody against said antigen
|
|
MX2019009726A
(es)
|
2018-04-17 |
2020-02-05 |
Molecular Templates Inc |
Moleculas con direccion hacia her2 que comprenden andamiajes de la sub-unidad a de la toxina shiga desinmunizados.
|
|
CN109265551B
(zh)
*
|
2018-09-25 |
2020-09-15 |
华东师范大学 |
Cd38抗体、嵌合抗原受体和药物
|
|
KR20210104736A
(ko)
|
2018-12-14 |
2021-08-25 |
모르포시스 아게 |
항체 제형
|
|
JP7687956B2
(ja)
|
2019-03-15 |
2025-06-03 |
モルフォシス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
自己抗体介在性自己免疫疾患の処置のための、抗ｃｄ３８抗体及びその医薬組成物
|
|
SG11202111943UA
(en)
|
2019-07-02 |
2021-11-29 |
Hutchinson Fred Cancer Res |
Recombinant ad35 vectors and related gene therapy improvements
|
|
TW202235435A
(zh)
|
2021-01-14 |
2022-09-16 |
德商莫菲西斯公司 |
抗cd38抗體及其用途
|
|
TW202302642A
(zh)
|
2021-03-01 |
2023-01-16 |
德商莫菲西斯公司 |
用於治療抗體介導移植物排斥用途之抗ｃｄ３８抗體
|
|
TW202321303A
(zh)
|
2021-07-19 |
2023-06-01 |
德商莫菲西斯公司 |
抗pla2r自體抗體媒介膜性腎病變之治療
|